← Back to Search

Other

High Resolution Retina Imaging (IHR Trial)

Paris, France
N/A
Waitlist Available
Led By Michel PAQUES
Research Sponsored by Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from date of inclusion until the date of last documented progression , assessed up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

To increase the clinical experience of using the rtx1 camera in various retinal disorders and to follow the evolution of structural alterations during retinal diseases using adaptive optics imaging with the rtx1 camera

See full description
Eligible Conditions
  • Macular Edema
  • Diabetic Retinopathy
  • Retinitis Pigmentosa
  • Retinal Vein Occlusion
  • Macular Degeneration
  • Retinal Degeneration
  • High Blood Pressure
  • Age-Related Macular Degeneration

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of inclusion until the date of last documented progression , assessed up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of inclusion until the date of last documented progression , assessed up to 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Evolution of retina diseases

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

Centre Hospitalier National d'Ophtalmologie des Quinze-VingtsLead Sponsor
21 Previous Clinical Trials
7,046 Total Patients Enrolled
3 Trials studying Macular Edema
2,670 Patients Enrolled for Macular Edema
Michel PAQUESPrincipal InvestigatorCentre Hospitalier National d'Ophtalmologie des Quinze-Vints
2 Previous Clinical Trials
2,400 Total Patients Enrolled
2 Trials studying Macular Edema
2,400 Patients Enrolled for Macular Edema
~124 spots leftby Mar 2026